Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
FP09 - Novel Therapeutics and Targeted Therapies
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Novel Therapeutics and Targeted Therapies
-
+
FP09.02 - Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes From EXCLAIM Extension Cohort
00:00 - 00:00 | Presenter: Maria Rosario García Campelo
- Abstract
Loading...
-
+
P50 - Novel Therapeutics and Targeted Therapies - EGFR Minor
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P50.03 - A Real-World Cohort Study of EGFR TKIs in Patients with NSCLC with Uncommon EGFR mutations (UpSwinG)
00:00 - 00:00 | Presenter: Satoru Miura
- Abstract
Loading...
-
+
P51 - Novel Therapeutics and Targeted Therapies - EGFR Resistance
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P51.05 - Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm+ NSCLC and Acquired T790M: The Real-World UpSwinG study
00:00 - 00:00 | Presenter: Sanjay Popat
- Abstract
Loading...
-
+
OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic
- 20:00 - 21:00
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Nursing and Allied Health Professionals
- Moderators:Sara McLaughlin-Barrett
-
+
OA17.04 - The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers
20:30 - 20:40 | Presenter: Anne-Marie Baird
- Abstract
Loading...
-
+
ES20 - Caveats, Challenges, and Controversies in Immunotherapy of Lung Cancer: Phase II and Phase III Trials*
- 20:30 - 21:05
- 9/14/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Immunotherapy (Phase II/III Trials)
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:David R. Gandara, Myung-Ju Ahn
-
+
ES20.02 - Charting a New Path: Defining Better Endpoints in Immune Therapy Trials in Lung Cancer
20:32 - 20:34 | Presenter: Sanjay Popat
- Abstract
Loading...
